Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vitamin K Antagonist”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03285100
What this trial is testing

The Effects of Discontinuation of Vitamin K Antagonists on the Rate of Elastin Degradation

Who this might be right for
Emphysema or COPDAneurysmCystic Fibrosis+1 more
Canisius-Wilhelmina Hospital 30
Not applicableStudy completedNCT03757481
What this trial is testing

Long-term Outcome After Heparin and Edoxaban Versus Heparin Plus Vit K Antagonists for Acute DVT and PE

Who this might be right for
Post Thrombotic SyndromeDeep Vein ThrombosisChronic Thromboembolic Pulmonary Hypertension
University Hospital, Montpellier 156
Not applicableStudy completedNCT02823093
What this trial is testing

Aortic Calcification and Vitamin K Antagonists

Who this might be right for
Vascular Calcification
Centre Hospitalier Universitaire, Amiens 73
Not applicableStudy completedNCT03645655
What this trial is testing

PIVKA-II Combined With Alpha-Fetoprotein for Diagnostic and Prognostic Value of Hepatic Tumors in Infants

Who this might be right for
HepatoblastomaHepatic Hemangioendothelioma
Shanghai Children's Medical Center 257
Not applicableStudy completedNCT05195372
What this trial is testing

Effectivity and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid Syndrome

Who this might be right for
Antiphospholipid SyndromeVenous ThromboembolismArterial Thromboembolism+1 more
Cardioangiologisches Centrum Bethanien 80
Not applicableStudy completedNCT03462446
What this trial is testing

Analysis of the Potential Savings of Rivaroxaban Events Versus Vitamin K Antagonists Events

Who this might be right for
Atrial Fibrillation
Bayer 249
Testing effectiveness (Phase 2)Study completedNCT01348074
What this trial is testing

Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K Antagonist

Who this might be right for
Atrial FibrillationVenous ThromboembolismHeart Valve Disease+1 more
McMaster University 104
Testing effectiveness (Phase 2)Study completedNCT02981472
What this trial is testing

The Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation

Who this might be right for
Thrombosis
Bristol-Myers Squibb 192
Not applicableStudy completedNCT02661516
What this trial is testing

Clinical and Economic Burden of Bleeding Events in Patients in the UK With Non-valvular Atrial Fibrillation Treated With Vitamin k Antagonists

Who this might be right for
Atrial Fibrillation
Bristol-Myers Squibb 16,513
Not applicableEnded earlyNCT03977363
What this trial is testing

The Portuguese Survey on Anticoagulated Patients Register (START-Portugal-Register)

Who this might be right for
Atrial FibrillationVenous ThromboembolismHeart Valve Diseases or Prosthesis
CHAD 25
Not applicableUnknownNCT02987062
What this trial is testing

MultiCenter expeRience in AFib Patients Treated With OAC (CRAFT)

Who this might be right for
Atrial Fibrillation
Medical University of Warsaw 2,000
Not applicableLooking for participantsNCT06823466
What this trial is testing

Advancing Knowledge in Ischemic Stroke Patients on Oral Anticoagulants

Who this might be right for
Ischemic StrokeOral AnticoagulationAtrial Fibrillation (AF)+2 more
University of L'Aquila 200
Large-scale testing (Phase 3)Study completedNCT03153150
What this trial is testing

Start or STop Anticoagulants Randomised Trial (SoSTART)

Who this might be right for
Intracranial HemorrhagesIntracranial Hemorrhage, HypertensiveSubarachnoid Hemorrhage+6 more
University of Edinburgh 203
Not applicableUnknownNCT06144866
What this trial is testing

Evaluataion of NOAC Levels in Acute Stroke

Who this might be right for
Ischemic StrokeAnticoagulant Adverse Reaction
National Taiwan University Hospital 1,000
Not applicableStudy completedNCT03993119
What this trial is testing

This Study Observes the Usage of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) in Elderly Patients With a Heart Rhythm Disorder in Spain

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 500
Very early researchNot Yet RecruitingNCT07011095
What this trial is testing

DOAC or VKA in Patients With AF and Stroke While on DOAC - a Pilot Trial

Who this might be right for
Atrial Fibrillation (AF)Stroke (in Patients With Atrial Fibrillation)
Population Health Research Institute 100
Large-scale testing (Phase 3)UnknownNCT02522221
What this trial is testing

Tecarfarin Anti-Coagulation Trial (TACT)

Who this might be right for
ThromboembolismThrombosis
Espero Biopharma 1,000
Not applicableStudy completedNCT01722786
What this trial is testing

Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists

Who this might be right for
Severe BleedingUrgent Surgery
Cardioangiologisches Centrum Bethanien 272
Post-approval studies (Phase 4)Looking for participantsNCT04258488
What this trial is testing

Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacement

Who this might be right for
AORTIC VALVE DISEASESThromboembolism
Joon Bum Kim 1,300
Not applicableUnknownNCT02906527
What this trial is testing

Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 75 Years and Over Suffering From Non Valvular Atrial Fibrillation (nv AF)

Who this might be right for
Non Valvular Atrial Fibrillation (nv AF)
Assistance Publique - Hôpitaux de Paris 150,000
Next Page